## **Core Concept**
The question tests the understanding of antibiotic resistance, specifically methicillin resistance in *Staphylococcus aureus* (MRSA), and the selection of appropriate antibiotics for treatment. MRSA infections are a significant concern due to their resistance to beta-lactam antibiotics, including methicillin, oxacillin, and penicillin.

## **Why the Correct Answer is Right**
MRSA infections require antibiotics that are effective against methicillin-resistant strains. Common treatments include vancomycin, daptomycin, linezolid, and clindamycin (though resistance rates to clindamycin can vary). The correct answer will be an antibiotic that is not suitable for treating MRSA infections.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Vancomycin is a glycopeptide antibiotic and is considered a first-line treatment for serious MRSA infections, making it an appropriate choice.
- **Option B:** Linezolid is an oxazolidinone antibiotic effective against MRSA and is used for treating skin and soft tissue infections, among other conditions.
- **Option D:** Clindamycin can be used to treat MRSA infections, although its use is limited by resistance in some MRSA strains.

## **Clinical Pearl / High-Yield Fact**
A critical point to remember is that MRSA infections are resistant to all beta-lactam antibiotics (e.g., penicillins, cephalosporins, carbapenems, and monobactams) due to an alteration in penicillin-binding proteins. Therefore, when treating MRSA, one must avoid these classes of antibiotics.

## **Correct Answer Line**
**Correct Answer:** .